Dr. Reddy’s Laboratories Ltd. Announces Five ANDA Approvals and Generic Product Launches in the US Market

February 5, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched the following five products in the US market during the month of January:

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Asia